These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada. Zhang T; Smith MA; Camp PG; Carleton BC Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540 [TBL] [Abstract][Full Text] [Related]
4. The impact of inappropriate use of short acting beta agonists in asthma. FitzGerald JM; Tavakoli H; Lynd LD; Al Efraij K; Sadatsafavi M Respir Med; 2017 Oct; 131():135-140. PubMed ID: 28947020 [TBL] [Abstract][Full Text] [Related]
5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
6. Has Asthma Medication Use Caught Up With the Evidence?: A 12-Year Population-Based Study of Trends. Sadatsafavi M; Tavakoli H; Lynd L; FitzGerald JM Chest; 2017 Mar; 151(3):612-618. PubMed ID: 27815152 [TBL] [Abstract][Full Text] [Related]
7. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167 [TBL] [Abstract][Full Text] [Related]
8. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam. ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236 [TBL] [Abstract][Full Text] [Related]
9. Comparing Ran-Out Status of Inhaled Short-Acting Beta-Agonists in Emergency Department Patients with Acute Asthma: 1996-1998 versus 2015-2017. Goto T; Camargo CA; Gimenez-Zapiola C; Pallin DJ; Shapiro NI; Ferro TJ; Rainville C; Stoyanov S; Hasegawa K J Allergy Clin Immunol Pract; 2018; 6(6):1999-2005.e3. PubMed ID: 29653218 [TBL] [Abstract][Full Text] [Related]
10. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050 [TBL] [Abstract][Full Text] [Related]
11. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575 [TBL] [Abstract][Full Text] [Related]
12. Short-acting beta-agonist prescription fills as a marker for asthma morbidity. Naureckas ET; Dukic V; Bao X; Rathouz P Chest; 2005 Aug; 128(2):602-8. PubMed ID: 16100144 [TBL] [Abstract][Full Text] [Related]
13. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Stanford RH; Blanchette CM; Roberts MH; Petersen H; Fuhlbrigge AL Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk factors and health outcomes among persons with asthma. Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629 [TBL] [Abstract][Full Text] [Related]
15. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink. Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. Merchant RK; Inamdar R; Quade RC J Allergy Clin Immunol Pract; 2016; 4(3):455-63. PubMed ID: 26778246 [TBL] [Abstract][Full Text] [Related]
17. Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma. Grimaldi-Bensouda L; Zureik M; Aubier M; Humbert M; Levy J; Benichou J; Molimard M; Abenhaim L; Chest; 2013 Feb; 143(2):398-405. PubMed ID: 23505637 [TBL] [Abstract][Full Text] [Related]
18. Relationship between asthma drug therapy patterns and healthcare utilization. Shireman TI; Heaton PC; Gay WE; Cluxton RJ; Moomaw CJ Ann Pharmacother; 2002 Apr; 36(4):557-64. PubMed ID: 11918499 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients treated with fluticasone propionate or montelukast sodium. Allen-Ramey FC; Duong PT; Goodman DC; Sajjan SG; Nelsen LM; Markson L Manag Care Interface; 2003 Aug; 16(8):30-5. PubMed ID: 12964550 [TBL] [Abstract][Full Text] [Related]
20. Quality of care for acute asthma in emergency departments in Japan: a multicenter observational study. Hasegawa K; Chiba T; Hagiwara Y; Watase H; Tsugawa Y; Brown DF; Camargo CA; J Allergy Clin Immunol Pract; 2013; 1(5):509-15.e1-3. PubMed ID: 24565623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]